Insider Selling: Cipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in Stock

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the business’s stock in a transaction dated Monday, March 24th. The shares were sold at an average price of C$13.49, for a total transaction of C$47,215.00.

Cipher Pharmaceuticals Stock Down 1.3 %

Shares of TSE CPH opened at C$12.16 on Thursday. Cipher Pharmaceuticals Inc. has a 1 year low of C$7.90 and a 1 year high of C$19.69. The company has a market capitalization of C$218.31 million, a P/E ratio of 13.43 and a beta of 1.20. The company has a 50 day simple moving average of C$12.82 and a 200-day simple moving average of C$14.34. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.